BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7696263)

  • 1. Structural basis of inhibitor affinity to variants of human carbonic anhydrase II.
    Nair SK; Krebs JF; Christianson DW; Fierke CA
    Biochemistry; 1995 Mar; 34(12):3981-9. PubMed ID: 7696263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of catalytic activity and stability of carbonic anhydrase II as revealed by random mutagenesis.
    Krebs JF; Fierke CA
    J Biol Chem; 1993 Jan; 268(2):948-54. PubMed ID: 8419374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural consequences of hydrophilic amino acid substitutions in the hydrophobic pocket of human carbonic anhydrase II.
    Nair SK; Christianson DW
    Biochemistry; 1993 May; 32(17):4506-14. PubMed ID: 8485129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected binding mode of the sulfonamide fluorophore 5-dimethylamino-1-naphthalene sulfonamide to human carbonic anhydrase II. Implications for the development of a zinc biosensor.
    Nair SK; Elbaum D; Christianson DW
    J Biol Chem; 1996 Jan; 271(2):1003-7. PubMed ID: 8557623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide.
    Di Fiore A; Monti SM; Hilvo M; Parkkila S; Romano V; Scaloni A; Pedone C; Scozzafava A; Supuran CT; De Simone G
    Proteins; 2009 Jan; 74(1):164-75. PubMed ID: 18618712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural influence of hydrophobic core residues on metal binding and specificity in carbonic anhydrase II.
    Cox JD; Hunt JA; Compher KM; Fierke CA; Christianson DW
    Biochemistry; 2000 Nov; 39(45):13687-94. PubMed ID: 11076507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray crystallographic studies of alanine-65 variants of carbonic anhydrase II reveal the structural basis of compromised proton transfer in catalysis.
    Scolnick LR; Christianson DW
    Biochemistry; 1996 Dec; 35(51):16429-34. PubMed ID: 8987974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of His94-->Asp carbonic anhydrase II in a new crystalline form reveals a partially occupied zinc binding site.
    Ippolito JA; Nair SK; Alexander RS; Kiefer LL; Fierke CA; Christianson DW
    Protein Eng; 1995 Oct; 8(10):975-80. PubMed ID: 8771178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering a cysteine ligand into the zinc binding site of human carbonic anhydrase II.
    Kiefer LL; Krebs JF; Paterno SA; Fierke CA
    Biochemistry; 1993 Sep; 32(38):9896-900. PubMed ID: 8399158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of inhibitor binding to human carbonic anhydrase II.
    Boriack-Sjodin PA; Zeitlin S; Chen HH; Crenshaw L; Gross S; Dantanarayana A; Delgado P; May JA; Dean T; Christianson DW
    Protein Sci; 1998 Dec; 7(12):2483-9. PubMed ID: 9865942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of the hydrogen bond to zinc ligand histidine-119 dramatically diminishes catalysis and enhances metal equilibration kinetics in carbonic anhydrase II.
    Huang CC; Lesburg CA; Kiefer LL; Fierke CA; Christianson DW
    Biochemistry; 1996 Mar; 35(11):3439-46. PubMed ID: 8639494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering the zinc binding site of human carbonic anhydrase II: structure of the His-94-->Cys apoenzyme in a new crystalline form.
    Alexander RS; Kiefer LL; Fierke CA; Christianson DW
    Biochemistry; 1993 Feb; 32(6):1510-8. PubMed ID: 8431430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of carbonic anhydrase from Neisseria gonorrhoeae and its complex with the inhibitor acetazolamide.
    Huang S; Xue Y; Sauer-Eriksson E; Chirica L; Lindskog S; Jonsson BH
    J Mol Biol; 1998; 283(1):301-10. PubMed ID: 9761692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histidine --> carboxamide ligand substitutions in the zinc binding site of carbonic anhydrase II alter metal coordination geometry but retain catalytic activity.
    Lesburg CA; Huang C; Christianson DW; Fierke CA
    Biochemistry; 1997 Dec; 36(50):15780-91. PubMed ID: 9398308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of human carbonic anhydrase II variants with altered zinc binding sites.
    Kiefer LL; Fierke CA
    Biochemistry; 1994 Dec; 33(51):15233-40. PubMed ID: 7803385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural consequences of redesigning a protein-zinc binding site.
    Ippolito JA; Christianson DW
    Biochemistry; 1994 Dec; 33(51):15241-9. PubMed ID: 7803386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-assisted redesign of a protein-zinc-binding site with femtomolar affinity.
    Ippolito JA; Baird TT; McGee SA; Christianson DW; Fierke CA
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5017-21. PubMed ID: 7761440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A versatile polypeptide platform for integrated recognition and reporting: affinity arrays for protein-ligand interaction analysis.
    Enander K; Dolphin GT; Liedberg B; Lundström I; Baltzer L
    Chemistry; 2004 May; 10(10):2375-85. PubMed ID: 15146511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal binding specificity in carbonic anhydrase is influenced by conserved hydrophobic core residues.
    Hunt JA; Ahmed M; Fierke CA
    Biochemistry; 1999 Jul; 38(28):9054-62. PubMed ID: 10413479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the catalytic properties of human carbonic anhydrase III by site-directed mutagenesis.
    Jewell DA; Tu CK; Paranawithana SR; Tanhauser SM; LoGrasso PV; Laipis PJ; Silverman DN
    Biochemistry; 1991 Feb; 30(6):1484-90. PubMed ID: 1899618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.